ADAPTIN BIO, INC. EFFECT, filed Jul 22, 2026: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 22, 2026 |
| Accession Number: | 0001213900-26-080096 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||